Transaction
|
December 14, 2021

Synthetic Biologics to acquire VCN Biosciences for over $4M in upfront cash

Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.